1. Signaling Pathways
  2. Neuronal Signaling
  3. CaMK
  4. CaMK II Isoform
  5. CaMK II Inhibitor

CaMK II Inhibitor

CaMK II Inhibitors (7):

Cat. No. Product Name Effect Purity
  • HY-N6732
    Inhibitor 99.45%
    K-252a, a staurosporine analog, inhibits protein kinase, with IC50 values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca2+/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively.
  • HY-13290
    Inhibitor 99.45%
    KN-62 is a selective and reversible inhibitor of calmodulin-dependent protein kinase II (CaMK-II) with a Ki of 0.9 μM for rat brain CaMK-II.
  • HY-P1029
    MLCK inhibitor peptide 18
    Inhibitor 99.66%
    MLCK inhibitor peptide 18 is a myosin light chain kinase (MLCK) inhibitor with an IC50 of 50 nM, and inhibits CaM kinase II only at 4000-fold higher concentrations.
  • HY-100779
    Inhibitor 99.65%
    Rimacalib (SMP 114) is a Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor, with IC50s of ~1 μM for CaMKIIα to ~30 μM for CaMKIIγ.
  • HY-137506
    Inhibitor 99.69%
    XST-14 is a potent, competitive and highly selective ULK1 inhibitor with an IC50 of 26.6 nM.
  • HY-W013857
    Lavendustin C
    Lavendustin C is a potent Ca2+ calmodulin-dependent kinase II (CaMK II) inhibitor with an IC50 of 0.2 µM.
  • HY-15720B
    Glycyl H-1152 hydrochloride
    Glycyl H-1152 hydrochloride (compound 18) is a glycyl derivative of Rho-kinase inhibitors H-1152 dihydrochloride.